Search

Your search keyword '"Bartolomei I."' showing total 174 results

Search Constraints

Start Over You searched for: Author "Bartolomei I." Remove constraint Author: "Bartolomei I."
174 results on '"Bartolomei I."'

Search Results

2. Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy

3. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

4. 11C-PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis

5. Effects of Venous Angioplasty on Cerebral Lesions in Multiple Sclerosis: Expanded Analysis of the Brave Dreams Double-Blind, Sham-Controlled Randomized Trial

6. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis

8. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

11. Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials

12. Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis

14. A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements

15. ATTRv amyloidosis Italian Registry: clinical and epidemiological data

16. Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study

17. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

20. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

21. HFE p.H63D polymorphism does not influence ALS phenotype and survival

22. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72

23. Genetic counselling in ALS: facts, uncertainties and clinical suggestions

24. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

25. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

26. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion

27. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

28. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients

29. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

30. Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients

31. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene

32. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

33. A further Rasch study confirms that ALSFRS-R does not conform to fundamental measurement requirements

34. Amyloidoma involving the orbit, Meckel’s cave and infratemporal fossa: 3T MRI findings

35. Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation

38. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion

39. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

40. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72

41. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population

42. TBK1 is associated with ALS and ALS-FTD in Sardinian patients

43. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry

44. CSF dynamics and brain volume in multiple sclerosis are associated with extracranial venous flow anomalies: a pilot study

45. Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls

47. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population

48. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72

49. FUS mutations in sporadic amyotrophic lateral sclerosis

50. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis

Catalog

Books, media, physical & digital resources